Executive Vice President, Discovery Research · Corvus Pharmaceuticals, Inc. (CRVS)

Joseph Buggy

FY2018 is the first fiscal year CompBrief holds for Joseph Buggy as a named executive officer of Corvus Pharmaceuticals; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,280,662

Salary $143,568Stock awards $0

2nd of 3 named executive officers at Corvus Pharmaceuticals by FY2018 total.

3 named officers on file for Corvus Pharmaceuticals, FY2018

Joseph Buggy’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Corvus Pharmaceuticals’s whole pay program stands against its peers

  • Corvus Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CRVS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2019 (DEF 14A).

Free

Get Joseph Buggy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Joseph Buggy compensation by year

Corvus Pharmaceuticals Summary Compensation Table · the one fiscal year held
In US dollars, as Corvus Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$143,568
Bonus$0
Stock awards$0
Option awards$1,137,094
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$1,280,662

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Corvus Pharmaceuticals, Inc. DEF 14A filed April 24, 2019, accession 0001558370-19-003229, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Corvus Pharmaceuticals, Inc. filed document, accession 0001558370-19-003229. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option77,083—$9.94
Option100,000—$5.94

Per the Outstanding Equity Awards at Fiscal Year-End table in Corvus Pharmaceuticals, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Corvus Pharmaceuticals’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Richard MillerPresident and Chief Executive Officer$1,362,313
Joseph Buggy · this pageExecutive Vice President, Discovery Research$1,280,662
Leiv LeaChief Financial Officer$746,661

The full Corvus Pharmaceuticals compensation record

free company brief

This page is one person within Corvus Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Corvus Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joseph Buggy's compensation dossier · One-time report. No refunds.